A vasoactive intestinal peptide antagonist inhibits the growth of glioblastoma cells

Author： Sharma Anita   Walters James   Gozes Yehoshua   Fridkin Mati   Brennman Douglas   Gozes Illana   Moody Terry  

Publisher： Humana Press, Inc

ISSN： 0895-8696

Source： Journal of Molecular Neuroscience, Vol.17, Iss.3, 2001-12, pp. : 331-339

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Effects of the vasoactive intestinal peptide (VIP) and related peptides on glioblastoma cell growth in vitro

By Dufes Christine   Alleaume Céline   Montoni Alicia   Olivier Jean-Christophe   Muller Jean-Marc  

Journal of Molecular Neuroscience, Vol. 21, Iss. 2, 2003-06 ,pp. : 91-102

Humana Press, Inc

Access to resources Recommend Favorite

(N-stearyl, norleucine17) VIPhybrid is a broad spectrum vasoactive intestinal peptide receptor antagonist

By Moody Terry   Jensen Robert   Fridkin Mati   Gozes Illana  

Journal of Molecular Neuroscience, Vol. 18, Iss. 1-2, 2002-02 ,pp. : 29-35

Humana Press, Inc

Access to resources Recommend Favorite

Expression and fine mapping of murine vasoactive intestinal peptide receptor 1

By Karacay Bahri   O’Dorisio M.Sue   Kasow Kim   Hollenback Clay   Krahe Ralf  

Journal of Molecular Neuroscience, Vol. 17, Iss. 3, 2001-12 ,pp. : 311-324

Humana Press, Inc

Access to resources Recommend Favorite

Vasoactive intestinal peptide in the brain of a mouse model for Down syndrome

By Hill J.M.   Ades A.M.   McCune S.K.   Sahir N.   Moody E.M.   Abebe D.T.   Crnic L.S.   Brenneman D.E.  

Experimental Neurology, Vol. 183, Iss. 1, 2003-09 ,pp. : 56-65

Elsevier

Access to resources Recommend Favorite

Vasoactive Intestinal Peptide (VIP) Regulates Activity-Dependent Neuroprotective Protein (ADNP) Expression In Vivo

By  

Journal of Molecular Neuroscience, Vol. 33, Iss. 3, 2007-11 ,pp. : 278-283

Humana Press, Inc

Access to resources Recommend Favorite